The Cancer Drug Development Forum – CDDF is the platform for all stakeholders involved in the development of cancer drugs.

Prof. Eva Skovlund

Eva Skovlund is professor of medical statistics at the Norwegian University of Science and Technology (NTNU) in Trondheim and senior researcher at the Norwegian Institute of Public Health (NIPH), Oslo, Norway. She is MSc in pharmacy/pharmacology and PhD in biostatistics. Her focus is on research methodology, and she supervises PhD students on projects utilising epidemiological data from registries and cohorts as well as design and analysis of clinical trials. Therapeutic areas include among others cancer, cardiovascular disease, drug use during pregnancy, and geriatrics. She has published more than 200 papers.

Skovlund has 10 years of regulatory experience in drug licencing at the Norwegian Medicines Agency and was the Norwegian member of CHMP (Committee for Human Medicinal Products) at the European Medicines Agency (EMA) 2002-2011. Her primary focus was the efficacy and safety of cancer products. She also chaired the Biostatistics Working Party (BSWP). During the period 1995-2015, she held positions as professor II at the University of Oslo, first at the Medical faculty, thereafter at the School of Pharmacy.

She was head of the Department of Pharmacoepidemiology and acting head of the Division of Epidemiology at the NIPH (2011-2015). She has been vice chair or board member of several organisations, among them the Norwegian Computing Centre (2009-2014) and the Norwegian Cancer Registry (2016-2019). Since 2014, she is board member of the National Committee for Medical & Health Research Ethics (NEM) in Norway.

 

 

 

Cancer Drug Development Forum asbl
Registered office: c/o BLSI, Clos Chapelle-aux-Champs 30, 1200 Woluwe Saint Lambert, Belgium
Register of legal entities: the French Speaking Enterprise Court in Brussels
Enterprise number: 738.523.752

info@cddf.org
Tel: +32 2 880 62 70